Weizhu Qian
- Molecular Biology top 10%
- Immunology top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Oncology top 5%
- Biomaterials top 5%
- Topics
- Monoclonal and Polyclonal Antibodies Research (42 papers)CAR-T cell therapy research (15 papers)Glycosylation and Glycoproteins Research (11 papers)
- Partner nations
- ChinaDenmarkUnited States
In The Last Decade
Weizhu Qian
84 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 124
- Molecular Biology 1.0k
- Immunology 652
- Radiology, Nuclear Medicine and Imaging 584
- Oncology 573
- Biomaterials 352
Countries citing papers authored by Weizhu Qian
This map shows the geographic impact of Weizhu Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizhu Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizhu Qian more than expected).
Fields of papers citing papers by Weizhu Qian
This network shows the impact of papers produced by Weizhu Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizhu Qian. The network helps show where Weizhu Qian may publish in the future.
Co-authorship network of co-authors of Weizhu Qian
This figure shows the co-authorship network connecting the top 25 collaborators of Weizhu Qian. A scholar is included among the top collaborators of Weizhu Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weizhu Qian. Weizhu Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 40 | |
| 3 | 22 | |
| 4 | 47 | |
| 5 | 15 | |
| 6 | 30 | |
| 7 | 8 | |
| 8 | 95 | |
| 9 | 4 | |
| 10 | 49 | |
| 11 | 10 | |
| 12 | 3 | |
| 13 | 47 | |
| 14 | 20 | |
| 15 | 81 | |
| 16 | 19 | |
| 17 | 19 | |
| 18 | 16 | |
| 19 | 36 | |
| 20 | 7 |
About Weizhu Qian
Weizhu Qian is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology, having authored 86 papers that have together received 2.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (42 papers), CAR-T cell therapy research (15 papers) and Glycosylation and Glycoproteins Research (11 papers). The work is most often cited by research in Immunology (652 citations), Biomaterials (352 citations) and Radiology, Nuclear Medicine and Imaging (584 citations). Weizhu Qian has collaborated with scholars based in China, Denmark and United States. Frequent co-authors include Bohua Li, Sheng Hou, Jianxin Dai, Yajun Guo, Yajun Guo, Jie Gao, Huaizu Guo, Geng Kou, Dapeng Zhang and Huaiwen Chen. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.